HOME >> MEDICINE >> NEWS
Aspirin and other non-specific COX inhibitors may slow atherosclerosis

Making sure cardiac patients take an aspirin a day to prevent a second heart attack is part of established treatment for most physicians, and many recommend the same regimen for patients at risk of suffering a first attack. But there has never been scientific evidence to demonstrate that this common, over-the-counter medication really provides any benefit in staving off the underlying condition of atherosclerosis.

Now, mouse-model research by scientists at the University of Pennsylvania School of Medicine has demonstrated that aspirin, ibuprofen and other drugs in the class of pharmaceuticals known as non-specific COX inhibitors may aid substantially in preventing heart disease, slowing the build-up of plaque in blood vessels by more than 50 percent.

"This study suggests that a product of the cyclooxegenase enzyme known as COX-1 -- which is the form targeted by aspirin in the prevention of heart attacks -- may also have a part to play in the gradual hardening of the arteries that precedes acute events like heart attack or stroke," said Garret A. FitzGerald, MD, chairman of Penns Department of Pharmacology. The research will be published March 13 in the Proceedings of the National Academy of Science.

The study also demonstrates that a separate class of drugs that specifically target the COX-2 enzyme -- so-called "super aspirins" such as Celebrex and Vioxx -- do not speed up the development of atherosclerosis, a concern based on some biochemical effects of those drugs. In their work, the Penn scientists scrutinized both known forms of the enzyme cyclooxygenase: COX-1, which is present throughout the body, and COX-2, which is present in some tissues, including the lining of the blood vessels.

COX-1 is the only form of the enzyme in platelets -- blood cells that stick together in the first stages of clotting. Suppression of the platelet COX-1 product, thromboxane, is how aspirin protects against heart attack and stroke.

The COX-2 enzyme produc
'"/>

Contact: Ellen O'Brien
ellen.obrien@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
6-Mar-2001


Page: 1 2 3

Related medicine news :

1. Aspirins potential ability to prevent colon polyps may not apply equally to all
2. Aspirin underused to reduce heart disease risk in diabetic women and young adults
3. Long Island Breast Cancer Study data: Aspirin helps protect some women against breast cancer
4. Aspirin use associated with reduced risk of breast cancer
5. Aspirin use may be associated with increased risk of pancreatic cancer
6. Aspirin is most cost effective way to prevent heart disease
7. Aspirin withdrawal may pose risk to coronary patients
8. Aspirin does not reduce effectiveness of ACE inhibitors
9. Aspirin may help prevent pancreatic cancer
10. Aspirins target, the COX-2 enzyme, linked to cancer of the uterus
11. Aspirin within two days of ischemic stroke reduces deaths

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2019)... ... January 19, 2019 , ... ... is responsible for ensuring the availability, quality and delivery of health care services ... Case Management, Quality Improvement, Pharmacy, Long-Term Services and Supports and Behavioral Health. In ...
(Date:1/15/2019)... ... ... Dr. James Petros, Medical Director of Allied Pain & Spine Institute ... thriving practice, which is located at 100 W. El Camino Real in Mountain View, ... the same comprehensive menu of pain management solutions as the other three clinics in ...
(Date:1/15/2019)... ... January 15, 2019 , ... Celebrating the 25th anniversary of Ultimate Medical ... the Pumas – to almost 2,000 employees and 150 students at UMA’s Tampa Bay ... At that time, UMA was a single campus with 25 students in Clearwater, Florida. ...
(Date:1/14/2019)... ... 2019 , ... LifeLearn Animal Health announces that it has ... be partnering with NAVC to deliver an all-new VetFolio—one-stop access to hundreds of ... managers and practice staff. , “We’re excited by the opportunity to invest in ...
(Date:1/14/2019)... ... January 14, 2019 , ... Modere (the “Company”), ... with a presence worldwide, today announced that it built on 2017’s growth momentum, ... grew by double-digits in North America, by more than five times in Europe ...
Breaking Medicine News(10 mins):
(Date:1/14/2019)... INDIANAPOLIS (PRWEB) , ... January 15, 2019 , ... Sigma ... of Nursing (AJN) Book of the Year Awards. These awards are regarded as one ... in its 49th year, the AJN Book of the Year competition has recognized Sigma ...
(Date:1/14/2019)... DEXTER, Mich. (PRWEB) , ... January 14, 2019 , ... Dexter foot and ankle podiatry ... and ankle care for all your foot and ankle needs! We can help take care ... hammertoe pain, top of the foot pain or even any heel or ankle ...
(Date:1/11/2019)... ... January 11, 2019 , ... ... The Gluten Free & Allergen Friendly Expo, is returning to the Del Mar ... lifestyles. In addition to the existing Gluten-Free and Nut-Free zones, Paleo, Keto, and ...
Breaking Medicine Technology:
Cached News: